{"DataElement":{"publicId":"2823587","version":"1","preferredName":"Imaging Contrast Agent Brand Name","preferredDefinition":"Text to represent the brand or marketed name for a medical imaging contrast agent.","longName":"IMAG_CONT_AGT_BD_NM","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2659493","version":"1","preferredName":"Image Contrast Bolus Agent","preferredDefinition":"The path of a Contrast or bolus agent. [Manually-curated]_An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"2423453v1.0:2659491v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2423453","version":"1","preferredName":"Image","preferredDefinition":"Any record of an imaging event whether physical or electronic.","longName":"C48179","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Image","conceptCode":"C48179","definition":"Any record of an imaging event whether physical or electronic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0434A55F-0E65-5760-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-28","endDate":null,"createdBy":"UMLLOADER_DUKE_P","dateCreated":"2005-10-28","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2659491","version":"1","preferredName":"Contrast Agent Bolus Infusion Agent","preferredDefinition":"Substances used in radiography that allow visualization of certain tissues.:A single dose of drug usually injected into a blood vessel over a short period of time.:An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C390:C15678:C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Contrast Agent","conceptCode":"C390","definition":"Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Bolus Infusion Procedure","conceptCode":"C15678","definition":"A procedure in which a single dose of a pharmalogical substance is administered, generally via injection, over a short period of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33B0B49B-5653-5E48-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-24","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-24","modifiedBy":"ONEDATA","dateModified":"2007-06-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435032","version":"1","preferredName":"Property or Attribute","preferredDefinition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","longName":"C20189","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-8321-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"33B0B49B-5664-5E48-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-24","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"10/22/08 - released post NCIA Interim Rpt Changes","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2823582","version":"1","preferredName":"Contrast Agent Brand Name","preferredDefinition":"Substances used in radiography that allow visualization of certain tissues._The part of the name or logo associated with a specific product or service identifying and distinguishing it from varieties of the same product or service marketed by competing companies._The words or language units by which a thing is known.","longName":"CONT_AGT_BRD_NM","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"16","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other (specify)","valueDescription":"Other, specify","ValueMeaning":{"publicId":"2823583","version":"1","preferredName":"Other, specify","longName":"2823583","preferredDefinition":"Different than the one(s) already noted","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6055793F-45BF-08BA-E040-BB89AD43386D","latestVersionIndicator":"Yes","beginDate":"2009-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6055793F-45D7-08BA-E040-BB89AD43386D","beginDate":"2009-01-12","endDate":null,"createdBy":"CDECURATE","dateCreated":"2009-01-12","modifiedBy":"CDECURATE","dateModified":"2009-01-12","deletedIndicator":"No"},{"value":"OPtiMark","valueDescription":"OPtiMark","ValueMeaning":{"publicId":"2823584","version":"1","preferredName":"OPtiMark","longName":"2823584","preferredDefinition":"OPtiMark","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6055793F-45E4-08BA-E040-BB89AD43386D","latestVersionIndicator":"Yes","beginDate":"2009-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6055793F-45FD-08BA-E040-BB89AD43386D","beginDate":"2009-01-12","endDate":null,"createdBy":"CDECURATE","dateCreated":"2009-01-12","modifiedBy":"CDECURATE","dateModified":"2009-01-12","deletedIndicator":"No"},{"value":"ProHance","valueDescription":"ProHance","ValueMeaning":{"publicId":"2735108","version":"1","preferredName":"ProHance","longName":"2735108","preferredDefinition":"ProHance (Gadoteridol Injection) is a nonionic contrast medium for magnetic resonance imaging (MRI), available as a 0.5M sterile clear colorless to slightly yellow aqueous solution in vials and syringes for intravenous injection.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4853F1FB-0D3B-1322-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-03-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6055793F-4613-08BA-E040-BB89AD43386D","beginDate":"2009-01-12","endDate":null,"createdBy":"CDECURATE","dateCreated":"2009-01-12","modifiedBy":"CDECURATE","dateModified":"2009-01-12","deletedIndicator":"No"},{"value":"Omniscan","valueDescription":"Omniscan","ValueMeaning":{"publicId":"2735109","version":"1","preferredName":"Omniscan","longName":"2735109","preferredDefinition":"OMNISCAN (gadodiamide) Injection is the formulation of the gadolinium complex of diethylenetriamine pentaacetic acid bismethylamide, and is an injectable, nonionic extracellular enhancing agent for magnetic resonance imaging.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4853F1FB-0D60-1322-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-03-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6055793F-4629-08BA-E040-BB89AD43386D","beginDate":"2009-01-12","endDate":null,"createdBy":"CDECURATE","dateCreated":"2009-01-12","modifiedBy":"CDECURATE","dateModified":"2009-01-12","deletedIndicator":"No"},{"value":"Magnevist","valueDescription":"Magnevist","ValueMeaning":{"publicId":"2823585","version":"1","preferredName":"Magnevist","longName":"2823585","preferredDefinition":"Magnevist","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6055793F-4635-08BA-E040-BB89AD43386D","latestVersionIndicator":"Yes","beginDate":"2009-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6055793F-464E-08BA-E040-BB89AD43386D","beginDate":"2009-01-12","endDate":null,"createdBy":"CDECURATE","dateCreated":"2009-01-12","modifiedBy":"CDECURATE","dateModified":"2009-01-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2823581","version":"1","preferredName":"Contrast Agent Brand Name Name","preferredDefinition":"Substances used in radiography that allow visualization of certain tissues.:The part of the name or logo associated with a specific product or service identifying and distinguishing it from varieties of the same product or service marketed by competing companies.:The words or language units by which a thing is known.","longName":"C390:C71898:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Contrast Agent","conceptCode":"C390","definition":"Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Proprietary Name","conceptCode":"C71898","definition":"The part of the name or logo associated with a specific product or service identifying and distinguishing it from varieties of the same product or service marketed by competing companies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6055793F-459B-08BA-E040-BB89AD43386D","latestVersionIndicator":"Yes","beginDate":"2009-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-12","modifiedBy":"ONEDATA","dateModified":"2009-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6055793F-45AC-08BA-E040-BB89AD43386D","latestVersionIndicator":"Yes","beginDate":"2009-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-12","modifiedBy":"ONEDATA","dateModified":"2009-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2813097","version":"1","longName":"Mass General Hospital","context":"NCIP"},{"publicId":"2813098","version":"1","longName":"MGH New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Brand of contrast injected","type":"Preferred Question Text","description":"Brand of contrast injected","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6055793F-465A-08BA-E040-BB89AD43386D","latestVersionIndicator":"Yes","beginDate":"2009-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-01-12","modifiedBy":"CHILLIJ","dateModified":"2013-04-29","changeDescription":"4/29/13 - removed manually-curarted from definition.  1/12/09 Curated to support MGH adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}